Retatrutide helped trial participants lose up to 28.7% of their body weight, but experts warn about excessive weight loss.

Larissa da Silva Caetano Anunciação, a Brazilian influencer, and her husband were reportedly arrested on Feb. 24 on suspicion ...

Luke Combs shared how his physical appearance has affected his mindset throughout his career as one of country music’s most successful artists.

Popular weight-loss drugs, including Ozempic, Wegovy, Trulicity and Mounjaro, produced by independent pharmacy labs, sickened ...

Weight loss drugs like Ozempic, Wegovy and Mounjaro have given millions of people hope. But scammers are cashing in — and experts say it could be ...

Too much of a good thing? Participants taking the highest dose of Eli Lilly’s new GLP-1 drug lost an average of 28.7% of their body weight in a late-stage trial, putting it on track to be a ...

I exercise most days, but the number on the scale never moves. What’s even the point? Exercise is not very effective for weight loss, but it’s incredibly beneficial for your physical and mental health ...

Jelly Roll showed off his dramatic weight loss at the Pre-Grammy Gala ahead of the 2026 Grammy Awards. The country singer, who once weighed roughly 550 pounds, appeared nearly unrecognizable as he ...

Orforglipron is a promising weight loss pill that could be a huge growth catalyst for Eli Lilly. The Food and Drug Administration has pushed back the target action date on the drug by nearly two weeks ...

When Jennifer Brown first started running, she did so with a clear goal in mind: to lose weight. And over the course of several years, she did just that, losing 190 pounds and reversing health risks ...

What started with Ozempic has become a new era in weight-loss success with blockbuster GLP-1 drugs like Wegovy and Zepbound helping fight obesity. But they’re just the beginning. New treatments that ...

Airlines stand to save a potential $580 million as travelers slim down thanks to the effects of weight-loss drugs, a new study found. Sheila Kahyaoglu, an equity analyst at Jefferies and an author of ...